Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012;7(4):e35020.
doi: 10.1371/journal.pone.0035020. Epub 2012 Apr 4.

Effect of CCR5-Δ32 heterozygosity on HIV-1 susceptibility: a meta-analysis

Sijie Liu  1 , Chuijin Kong, Jie Wu, Hao Ying, Huanzhang Zhu
Affiliations
Meta-Analysis

Effect of CCR5-Δ32 heterozygosity on HIV-1 susceptibility: a meta-analysis

Sijie Liu et al. PLoS One. 2012.

Abstract

Background: So far, many studies have investigated the distribution of CCR5 genotype between HIV-1 infected patients and uninfected people. However, no definite results have been put forward about whether heterozygosity for a 32-basepair deletion in CCR5 gene (CCR5-Δ32) can affect HIV-1 susceptibility.

Methods: We performed a meta-analysis of 18 studies including more than 12000 subjects for whom the CCR5-Δ32 polymorphism was genotyped. Odds ratio (OR) with 95% confidence interval (CI) were employed to assess the association of CCR5-Δ32 polymorphism with HIV-1 susceptibility.

Results: Compared with the wild-type CCR5 homozygotes, the pooled OR for CCR5-Δ32 heterozygotes was 1.02 (95%CI, 0.88-1.19) for healthy controls (HC) and 0.95 (95%CI, 0.71-1.26) for exposed uninfected (EU) controls. Similar results were found in stratified analysis by ethnicity, sample size and method of CCR5-Δ32 genotyping.

Conclusions: The meta-analysis indicated that HIV-1 susceptibility is not significantly affected by heterozygosity for CCR5-Δ32.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Selection process of studies included in the meta-analysis.
Figure 2
Figure 2. Odds ratio of HIV-1 infection of CCR5-Δ32 heterozygotes versus wild type CCR5 homozygotes.
The area of the black square reflects the weight of each study. The diamonds represent the combined odds ratio and 95% confidence interval using the fixed effects model for (a) healthy controls (HC) and (b) exposed uninfected controls (EU).
Figure 3
Figure 3. Funnel plots to detect publication bias in the meta-analysis.
(a) Healthy controls considered; (b) exposed uninfected controls considered. The horizontal line indicates the pooled log odds ratio (OR) and guidelines to assist in visualizing the funnel are pooled at 95% pseudo confidence limits for this estimate.
See this image and copyright information in PMC

References

    1. Kaur G, Mehra N. Genetic determinants of HIV-1 infection and progression to AIDS: susceptibility to HIV infection. Tissue Antigens; 2009;73:289–301. - PMC - PubMed
    1. O’Brien SJ, Moore JP. The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS. Immunol Rev; 2000;177:99–111. - PubMed
    1. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, et al. Homozygous defects in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell: 1996;86:367–77. - PubMed
    1. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science: 1996;273:1856–62. - PubMed
    1. Hütter G, Nowak D, Mossner M, Ganepola S, Müssiq A, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med; 2009;360:692–8. - PubMed

Publication types

Substances